Early diagnosis of ovarian cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells Epithelial Cells Breast Ascitic Fluid

Organisms2

Mice, Nude Mice, SCID

Diseases55

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Breast Neoplasms Carcinoma Neoplasm Invasiveness Adenocarcinoma, Clear Cell Lung Neoplasms Neoplasms Prostatic Neoplasms Genetic Predisposition to Disease Disease Progression Adenocarcinoma, Mucinous Neoplasm Metastasis Carcinoma, Endometrioid Peritoneal Neoplasms Ascites Pancreatic Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Recurrence, Local Cystadenocarcinoma Endometrial Neoplasms Uterine Cervical Neoplasms Adenocarcinoma Fallopian Tube Neoplasms Carcinoma, Squamous Cell Colorectal Neoplasms Neoplasms, Cystic, Mucinous, and Serous Genital Neoplasms, Female Neoplastic Syndromes, Hereditary Cell Transformation, Neoplastic Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Hereditary Breast and Ovarian Cancer Syndrome Liver Neoplasms Cystadenocarcinoma, Mucinous Mouth Neoplasms Precancerous Conditions Neovascularization, Pathologic Neoplasms, Multiple Primary Skin Neoplasms Cystadenoma, Serous Esophageal Neoplasms Neoplasms, Second Primary Rectal Neoplasms Adenocarcinoma, Papillary Recurrence Disease Models, Animal Gastrointestinal Neoplasms Breast Neoplasms, Male Head and Neck Neoplasms Acute Disease Syndrome Tuberculosis, Meningeal

Chemicals and Drugs47

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Cisplatin Paclitaxel Neoplasm Proteins BRCA2 Protein BRCA1 Protein Carboplatin RNA, Messenger Epididymal Secretory Proteins Antineoplastic Agents, Phytogenic DNA, Neoplasm Biological Markers Cancer Vaccines Antigens, Neoplasm RNA, Small Interfering Receptor, erbB-2 Tumor Suppressor Protein p53 Antibodies, Monoclonal Platinum Compounds Platinum Receptors, Estrogen MicroRNAs Topotecan Antigens, Tumor-Associated, Carbohydrate Prostate-Specific Antigen RNA, Neoplasm Taxoids Transcription Factors DNA Primers Receptors, Progesterone Tumor Suppressor Proteins Receptor, Epidermal Growth Factor DNA-Binding Proteins Organoplatinum Compounds Proto-Oncogene Proteins Tamoxifen Contraceptives, Oral Altretamine Proto-Oncogene Proteins c-akt Nuclear Proteins Fluorouracil Antineoplastic Agents, Hormonal Carcinoembryonic Antigen Deoxycytidine Mucin-1

Analytical, Diagnostic and Therapeutic Techniques and Equipment86

Early Diagnosis Early Detection of Cancer Sensitivity and Specificity Prognosis Retrospective Studies Delayed Diagnosis Neoplasm Staging Risk Factors Prospective Studies Follow-Up Studies Survival Analysis Survival Rate Predictive Value of Tests Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Polymerase Chain Reaction Tomography, X-Ray Computed Reproducibility of Results Xenograft Model Antitumor Assays Prenatal Diagnosis Genetic Testing Gene Expression Profiling Case-Control Studies Risk Immunohistochemistry Risk Assessment Incidence Biopsy Disease-Free Survival Combined Modality Therapy Registries Blotting, Western Enzyme-Linked Immunosorbent Assay Cohort Studies Odds Ratio Oligonucleotide Array Sequence Analysis Neoplasm Transplantation Magnetic Resonance Imaging Multivariate Analysis ROC Curve Questionnaires Kaplan-Meier Estimate Diagnostic Errors Logistic Models DNA Mutational Analysis Immunoenzyme Techniques Transplantation, Heterologous Neoplasm Grading Diagnosis Fatal Outcome Tissue Array Analysis Drug Screening Assays, Antitumor Confidence Intervals Biopsy, Needle Tumor Burden Mass Screening Prevalence Chemotherapy, Adjuvant SEER Program Mammography Flow Cytometry Drug Administration Schedule Transfection Pedigree Diagnostic Imaging Immunoassay Clinical Trials as Topic Diagnosis, Computer-Assisted False Positive Reactions Molecular Targeted Therapy Gene Knockdown Techniques Salpingectomy Molecular Diagnostic Techniques Models, Biological Disease Models, Animal Positron-Emission Tomography Chi-Square Distribution Real-Time Polymerase Chain Reaction Clinical Enzyme Tests Cross-Sectional Studies Severity of Illness Index Physical Examination False Negative Reactions Neonatal Screening Ultrasonography

Psychiatry and Psychology1

Phenomena and Processes43

Sensitivity and Specificity Genes, BRCA1 Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA2 Genetic Predisposition to Disease Time Factors Mutation Risk Germ-Line Mutation Cell Proliferation Odds Ratio Apoptosis DNA Methylation Genotype Cell Survival Pregnancy Heterozygote Cell Movement Up-Regulation Signal Transduction Polymorphism, Genetic Down-Regulation Cell Growth Processes Dose-Response Relationship, Drug Genes, Tumor Suppressor Cell Division Base Sequence Cell Cycle Phenotype Transfection RNA Interference Promoter Regions, Genetic Gene Silencing Algorithms Gene Expression Alleles Drug Synergism Genes, Neoplasm Genes, p53 Chi-Square Distribution Postmenopause Loss of Heterozygosity

Disciplines and Occupations4

Immunohistochemistry Genetic Counseling Medical Oncology Proteomics

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Registries Questionnaires Fatal Outcome Prevalence Base Sequence SEER Program Molecular Sequence Data Algorithms Diagnosis, Computer-Assisted

Named Groups3

Infant, Newborn Survivors Jews

Health Care41

Sensitivity and Specificity Retrospective Studies Risk Factors Prospective Studies Follow-Up Studies Survival Analysis Survival Rate Predictive Value of Tests Treatment Outcome Reproducibility of Results Genetic Testing Case-Control Studies Risk Age Factors Risk Assessment Incidence Disease-Free Survival Registries Cohort Studies Odds Ratio Multivariate Analysis ROC Curve Questionnaires Kaplan-Meier Estimate Diagnostic Errors Logistic Models Genetic Counseling Fatal Outcome Confidence Intervals Mass Screening Prevalence Age of Onset SEER Program National Cancer Institute (U.S.)Clinical Trials as Topic Age Distribution Family Health Chi-Square Distribution Cross-Sectional Studies Severity of Illness Index Neonatal Screening

Geographicals4

United States China Japan Italy

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Early Diagnosis Neoplasms, Glandular and Epithelial CA-125 Antigen Early Detection of Cancer Cystadenocarcinoma, Serous Sensitivity and Specificity Genes, BRCA1 Cell Line, Tumor Tumor Markers, Biological Breast Neoplasms Prognosis Gene Expression Regulation, Neoplastic Retrospective Studies Carcinoma Delayed Diagnosis Neoplasm Staging Antineoplastic Agents Drug Resistance, Neoplasm Neoplasm Invasiveness Risk Factors Mice, Nude Prospective Studies Genes, BRCA2 Adenocarcinoma, Clear Cell Cisplatin Follow-Up Studies Lung Neoplasms Survival Analysis Paclitaxel Neoplasms Prostatic Neoplasms Neoplasm Proteins Genetic Predisposition to Disease BRCA2 Protein Survival Rate Predictive Value of Tests Disease Progression Adenocarcinoma, Mucinous Neoplasm Metastasis Carcinoma, Endometrioid Peritoneal Neoplasms Antineoplastic Combined Chemotherapy Protocols BRCA1 Protein Treatment Outcome Reverse Transcriptase Polymerase Chain Reaction Ascites Polymerase Chain Reaction Time Factors Mutation Pancreatic Neoplasms Tomography, X-Ray Computed Stomach Neoplasms Reproducibility of Results Xenograft Model Antitumor Assays Prenatal Diagnosis Genetic Testing Gene Expression Profiling Colonic Neoplasms Neoplasm Recurrence, Local Case-Control Studies Risk Age Factors Immunohistochemistry Risk Assessment Germ-Line Mutation Incidence Biopsy Carboplatin Disease-Free Survival RNA, Messenger Tumor Cells, Cultured Cystadenocarcinoma United States Epididymal Secretory Proteins Antineoplastic Agents, Phytogenic Cell Proliferation Combined Modality Therapy DNA, Neoplasm Registries Blotting, Western Endometrial Neoplasms Uterine Cervical Neoplasms Adenocarcinoma Enzyme-Linked Immunosorbent Assay Cohort Studies Odds Ratio Biological Markers Cancer Vaccines Fallopian Tube Neoplasms Antigens, Neoplasm Apoptosis Ovary DNA Methylation Infant, Newborn Carcinoma, Squamous Cell Oligonucleotide Array Sequence Analysis Colorectal Neoplasms Neoplasm Transplantation Magnetic Resonance Imaging

No FAQ available that match "early diagnosis of ovarian cancer"